RIGL R&D Expenses
Rigel Pharmaceuticals Inc · R&D Expenses
RIGL R&D Expenses
Latest reported$43.68Mperiod ending
RIGL R&D Expenses ($17.11M → $43.68M)
Annual R&D Expenses
High-resolution chart · PNG
RIGL r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 33,295,000 | |
| 23,380,000 | |
| 24,522,000 | |
| 60,272,000 | |
| 65,237,000 | |
| 60,101,000 | |
| 52,885,000 | |
| 46,903,000 | |
| 46,269,000 | |
| 63,446,000 | |
| 62,825,000 | |
| 67,696,000 | |
| 75,328,000 | |
| 78,778,000 | |
| 69,350,000 | |
| 64,392,000 | |
| 90,743,000 | |
| 109,670,000 | |
| 70,364,000 | |
| 56,968,000 | |
| 52,038,000 | |
| 48,523,000 | |
| 43,363,000 | |
| 43,350,000 | |
| 32,313,000 | |
| 32,034,000 | |
| 17,112,000 |